Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arvaya HealthcareBOM:524723 -2.00%36 Days Inventory is 38.85 as of Mar. 2026, which is 57% below its 10-year median of 91.00. GuruFocus rates BOM:524723 with a GF Score™ of 36/100 and a GF Value™ of ₹49.82 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 116 Medical Distribution companies, Arvaya Healthcare ranks worse than 87.93% on this metric.
The historical rank and industry rank for Arvaya Healthcare's Days Inventory or its related term are showing as below:
BOM:524723'
s Days Inventory Range Over the Past 10 Years
Min: 42.49 Med: 91 Max: 155.42
Current: 155.42
During the past 13 years, Arvaya Healthcare's highest Days Inventory was 155.42. The lowest was 42.49. And the median was 91.00.
BOM:524723's Days Inventory is ranked worse than 87.93% of 116
companies
in the Medical Distribution industry
Industry Median: 57.495
vs BOM:524723: 155.42
Arvaya Healthcare's Days Inventory
increased
from Mar. 2025 (0.00) to Mar. 2026 (38.85).
It might indicate that Arvaya Healthcare's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Arvaya Healthcare's Inventory Turnover for the
three
months ended in Mar. 2026 was 2.35.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Arvaya Healthcare's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.21.
Arvaya Healthcare (BOM:524723) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Arvaya Healthcare's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Arvaya Healthcare's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Arvaya Healthcare Days Inventory Related Terms
Arvaya Healthcare Days Inventory Historical Data
* Premium members only.
The historical data trend for Arvaya Healthcare's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524723 vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, Arvaya Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvaya Healthcare Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where Arvaya Healthcare's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arvaya Healthcare (BOM:524723) has a Days Inventory of 38.85 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Arvaya Healthcare and its competitors. This is 57% below median its historical median of 91.00. Over the past decade, Arvaya Healthcare's Days Inventory has ranged from 42.49 to 155.42. According to the industry distribution chart, Arvaya Healthcare ranks #102 out of 116 companies in the Medical Distribution industry, placing it in the top 87.9%.
Is Arvaya Healthcare's Days Inventory too high?
Arvaya Healthcare's current Days Inventory of 38.85 is 57% below median its 10-year median of 91.00. Over the past 10 years, this metric has ranged from a low of 42.49 to a high of 155.42. The Medical Distribution industry median Days Inventory is 57.50. Arvaya Healthcare's value of 38.85 is 32.4% below this industry median. Based on the distribution chart, Arvaya Healthcare ranks #102 out of 116 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Arvaya Healthcare has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #102 out of 116 companies for Days Inventory. This places Arvaya Healthcare in the lower half of its industry. The industry median Days Inventory is 57.50. Arvaya Healthcare's value of 38.85 is 32.4% below this benchmark. Historically, Arvaya Healthcare's own Days Inventory has ranged from 42.49 to 155.42 over the past decade. While the company's 10-year median is 91.00 vs. the industry median of 57.50, Arvaya Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 57.50, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvaya Healthcare's current Days Inventory of 38.85 is 32.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Arvaya Healthcare and its competitors. For the Medical Distribution industry, the median Days Inventory is 57.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current Days Inventory is 38.85, which is 57% below median its own 10-year median of 91.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹49.82, compared to a current price of ₹131.58 — trading 164.1% above its estimated fair value. The current Days Inventory is 38.85, which is 57% below median its 10-year median of 91.00 and 32.4% below the Medical Distribution industry median of 57.50. Arvaya Healthcare's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current Days Inventory is 38.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?
Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be overvalued.
The current stock price of ₹131.58 is trading 164.1% above its estimated GF Value™ of ₹49.82.
GuruFocus considers Arvaya Healthcare to be Significantly Overvalued.
Key valuation signals for BOM:524723:
Days Inventory: 38.85 (57% below median its 10-year median of 91.00)
GF Value™: ₹49.82 vs. price of ₹131.58 (164.1% above fair value)
Industry Position: 32.4% below the Medical Distribution median (#102 of 116)
No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
36GF Score
Get the complete analysis for BOM:524723
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524723 has been successfully added to your 
